Hideaki Bujo

Sakura, 2858741, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

Diagnostic Value of sLR11 and sIL-2R in the Cerebrospinal Fluid for Malignant Central Nervous System Lymphoma.

Diagnostic Value of sLR11 and sIL-2R in the Cerebrospinal Fluid for Malignant Central Nervous System Lymphoma.

Journal: Internal medicine (Tokyo, Japan)

Published: March 03, 2024

Genetic assessment using whole-exome sequencing for a young hypertriglyceridemic patient with repeated acute pancreatitis.

Genetic assessment using whole-exome sequencing for a young hypertriglyceridemic patient with repeated acute pancreatitis.

Journal: Endocrine journal

Published: April 07, 2022

Soluble LR11 as a Novel Biomarker in Acute Kawasaki Disease.

Soluble LR11 as a Novel Biomarker in Acute Kawasaki Disease.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: September 16, 2021

Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.

Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.

Journal: Journal of atherosclerosis and thrombosis

Published: August 30, 2021

Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study.

Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study.

Journal: Journal of atherosclerosis and thrombosis

Published: June 10, 2021

Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.

Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.

Journal: Journal of atherosclerosis and thrombosis

Published: May 13, 2021

Integrated Analysis of Two Probucol Trials for the Secondary Prevention of Atherosclerotic Cardiovascular Events: PROSPECTIVE and IMPACT.

Integrated Analysis of Two Probucol Trials for the Secondary Prevention of Atherosclerotic Cardiovascular Events: PROSPECTIVE and IMPACT.

Journal: Journal of atherosclerosis and thrombosis

Published: April 19, 2021

Current Status of Familial LCAT Deficiency in Japan.

Current Status of Familial LCAT Deficiency in Japan.

Journal: Journal of atherosclerosis and thrombosis

Published: April 19, 2021

High presepsin concentrations in bile and its marked elevation in biliary tract diseases: A retrospective analysis.

High presepsin concentrations in bile and its marked elevation in biliary tract diseases: A retrospective analysis.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: February 24, 2021

Esterification of 4β-hydroxycholesterol and other oxysterols in human plasma occurs independently of LCAT.

Esterification of 4β-hydroxycholesterol and other oxysterols in human plasma occurs independently of LCAT.

Journal: Journal of lipid research

Published: June 21, 2020

Impact of LR11 as Residual Risk on Long-Term Clinical Outcomes in Patients with Coronary Artery Disease Treated with Statins after First Percutaneous Coronary Intervention.

Impact of LR11 as Residual Risk on Long-Term Clinical Outcomes in Patients with Coronary Artery Disease Treated with Statins after First Percutaneous Coronary Intervention.

Journal: International heart journal

Published: May 01, 2020

Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE).

Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE).

Journal: Journal of atherosclerosis and thrombosis

Published: April 28, 2020

Showing 1-12 of 81

Last Updated: 09/26/2026